Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: At a genomic level metastatic castrate resistant prostate cancer state is highly heterogeneous and no clear genome-based prognostic or predictive biomarkers exist in practice. We evaluated multiple copy number somatic alterations in two castrate resistant patient cohorts to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinyong, Du, Meijun, Soupir, Alex, Wang, Liewei, Tan, Winston, Kalari, Krishna R., Kilari, Deepak, Park, Jong, Huang, Chiang-Ching, Kohli, Manish, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562906/
https://www.ncbi.nlm.nih.gov/pubmed/36230636
http://dx.doi.org/10.3390/cancers14194714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562906/
https://www.ncbi.nlm.nih.gov/pubmed/36230636
http://dx.doi.org/10.3390/cancers14194714

Ejemplares similares